A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis

New York Eye & Ear Hospital, New York

Wilmer Eye Institute, Baltimore

Viginia Eye Consultants, Norfolk

Associated Retinal Consultants, PC, Grand Rapids

University of Illinois - Chicago, Chicago

Tauber Eye Center, Kansas City

Retina & Uveitis Consultants of Texas, San Antonio

Brian B. Berger, MD, P.A., Austin

Retinal Consultants of Arizona, Phoenix

Oregon Health Sciences University, Portland

University of Alabama at Birmingham, Birmingham

Massachusetts Eye and Ear Infirmary, Boston

Duke University Eye Center, Erwin Road, Durham

Universitätsklinik für Augenheilkunde, Salzburg

Klinik für Augenheilkunde, Dept. of Ophthalmology, Vienna

Hôpital Pitié Salpétrière, Service d'Ophtalmologie, Paris

Universitätsklinikum Freiburg, Freiburg im Breisgau

Augenklinik der Universität Heidelberg, Heidelberg

St. Franziskus-Hospital, Münster

Universitätsklinikum Tübingen, Tübingen

L V Prasad Eye Institute, Hyderabaad

Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai

Vittala International Institute of Ophthalmology, Bangalore

Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh

Aravind Eye Hospital, Uvea Clinic, Coimbatore

Aditya Jyot Eye Hospital Pvt Ltd, Mumbai

Bristol Eye Hospital and University of Bristol, Bristol

Royal Liverpool University Hospital, Liverpool

Massachusetts Eye Research and Surgery Institute, Cambridge

McGill University Health Center, Montreal